Stock Groups

EU regulator evaluating use of Pfizer’s COVID-19 vaccine in young children By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Susanne Wohlgemuth is a pharmacist who prepares Pfizer/BioNTech vaccines for the Haus an der Linde in Lichtentanne. It’s the day that Germany will start its immunization programme. Hendrik Schmidt/P

(Reuters) – On Monday, the European Union’s medicine regulator announced that it had begun evaluating how medicines are used. Pfizer Inc (NYSE 🙂 and BioNTech’s COVID-19 vaccine for children between 5 and 11 years old.

European Medicines Agency stated that it would review all data related the Comirnaty vaccine. It will also consider results from a continuing clinical study with young children.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]